Mediaone Global (503685)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Return on capital employed of 165.29% is exceptionally high on reported capital, suggesting efficient capital use if the balance sheet is reliable.
• Return on equity of 8.22% is positive, though modest, and implies some existing profitability before the recent deterioration.
• Market capitalisation of ₹65 crore is small, so a successful turnaround or a single hit film could have a material impact on per-share value.

Concerns

• Sales growth is -43.21% and the latest quarter revenue is only ₹1 crore, showing severe business contraction.
• Profit growth of -1671.43% and a latest-quarter net loss of ₹1 crore mean there is no current earnings support for the price.
• Piotroski F-Score of 3/9 indicates weak financial health and multiple red flags.
• Valuation is unsupported: ₹65 crore market cap against no earnings, no book value, no promoter holding disclosure and no dividend.

AI Analysis

I have learned to be suspicious when a business produces numbers that do not support its share price. Mediaone Global sells at ₹42.68, at the top of its 52-week range, and the market capitalizes it at ₹65 crore. Yet the latest quarter shows sales of only ₹1 crore and a net loss of ₹1 crore. Annualise that and you get roughly ₹4 crore in revenue against a ₹65 crore price. There is no positive earnings stream, no dividend, no disclosed book value, and no disclosure of promoter holding. Graham would call this speculation, not investment. Sales have collapsed 43.21%, and profit growth has deteriorated by 1671.43%. The Piotroski F-Score of 3 out of 9 points to weak financial health. A high ROCE of 165.29% sounds impressive, but I must question how much capital is actually left in the business; ROE at 8.22% is only modest. In film production, distribution and exhibition, the moat is thin. Success depends on hits, not on durable competitive advantages. There is little evidence of pricing power or recurring revenue. The stock is at its 52-week high, which may excite traders, but a value investor buys a business only when its price is demonstrably less than its intrinsic worth. I cannot calculate intrinsic worth here because the earnings and capital data are either negative or missing. This looks like a cyclical/turnaround situation at best, and a value trap at worst. I would need to see meaningful sales recovery, clear balance sheet information, and a sustained return to profitability before investing a rupee. Until then, this is a pass for me.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer